Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Pain 1

Interventions

Fibroblast Growth Factor 7 9avasopasem manganese 4Low-Level Light Therapy 4Cisplatin 4Mouthwashes 3Control Groups 3Water 2Standard of Care 2Sodium Chloride 2Sodium Bicarbonate 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Propolis 2Laser Therapy 2Injections 2FGF20 protein, human 2Drug Therapy 2Chlorhexidine 2Benzydamine 2Ascorbic Acid 2whole grape extract 1sargramostim 1samital 1peppermint oil 1oxycodone-acetaminophen 1meclocycline 1golotimod 1dusquetide 1calcium phosphate 1brilacidin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Stomatitis × Amidines × Clear all
NCT02531906 2022-07-25

Gabapentin, Methadone Hydrochloride, and Oxycodone Hydrochloride in Improving Quality of Life in Patients With Stage II-IV Head and Neck Cancer During Chemoradiation

Roswell Park Cancer Institute

Phase 1 Completed
60 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Pain, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡